Custom-Made vaccine aims to boost immune attack on kidney tumors
Disease control
Not yet recruiting
This early-stage trial tests whether a personalized vaccine, made from each patient's unique tumor mutations, can safely boost the effects of the immunotherapy drug pembrolizumab in people with advanced kidney cancer. The vaccine is designed to train the immune system to recogniz…
Phase: PHASE1 • Sponsor: Jian Lin • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC